CardiaTec
CardiaTec
Claim
CardiaTec is developing a target discovery platform leveraging AI to make sense of large-scale multiomic cardiovascular data. As opposed to conventional singular omic analysis, CardiaTec’s proprietary platform unravels relationships that span across every level of biology, from gene variation, methylation and expression, to their connection to proteomic and metabolomic functions to best understand disease development.CardiaTec is developing a target discovery platform leveraging AI to make sense of large-scale multi Show More
Alpha Score
$ 8.55 M
Alpha Score
48.1
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0